Wetzel Investment Advisors’s Merck MRK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$386K Sell
2,983
-421
-12% -$49.3K 0.13% 86
2026
Q1
$412K Sell
3,404
-316
-8% -$36.5K 0.16% 82
2025
Q4
$395K Sell
3,720
-268
-7% -$25.2K 0.16% 80
2025
Q3
$338K Sell
3,988
-73
-2% -$6.01K 0.14% 87
2025
Q2
$325K Sell
4,061
-634
-14% -$50.4K 0.15% 90
2025
Q1
$425K Sell
4,695
-119
-2% -$11.1K 0.21% 74
2024
Q4
$483K Sell
4,814
-49
-1% -$5.05K 0.24% 68
2024
Q3
$556K Buy
4,863
+323
+7% +$38.4K 0.28% 64
2024
Q2
$599K Sell
4,540
-296
-6% -$38.1K 0.34% 53
2024
Q1
$606K Buy
4,836
+497
+11% +$61.3K 0.36% 48
2023
Q4
$473K Buy
+4,339
New +$450K 0.29% 56

Other funds holding MRK

Wetzel Investment Advisors's MRK Position: Q2 2026 in Review

Wetzel Investment Advisors reduced its Merck (MRK) stake by 12% in Q2 2026, selling an estimated $49.3K and leaving 2,983 shares worth $386K. The position accounts for 0.13% of the portfolio, ranked #86.

Wetzel Investment Advisors first reported a position in MRK in Q4 2023 and has held it in 11 quarters since. The position peaked at $606K in Q1 2024. 1,769 funds tracked by Wall St. Rank hold MRK as of Q2 2026.

  • Wetzel Investment Advisors held 2,983 shares of Merck worth $386K as of Q2 2026.
  • Wetzel Investment Advisors sold 421 Merck shares in Q2 2026, an estimated $49.3K.
  • Merck made up 0.13% of Wetzel Investment Advisors's portfolio in Q2 2026, its #86 holding.
  • Wetzel Investment Advisors first reported a position in Merck in Q4 2023 and has held it in 11 quarters since.
  • Wetzel Investment Advisors's Merck position peaked at $606K in Q1 2024.
  • 1,769 funds tracked by Wall St. Rank held Merck as of Q2 2026.

Based on Wetzel Investment Advisors's 13F filing for Q2 2026, filed 23 Jul 2026.